Invesco’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Invesco’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,776	Closed	-$277K	–	3754
2020 Q1	$277K	Buy	+5,776	New	+$269K	﹤0.01%	3294
2019 Q4	–	Sell	-2,192,020	Closed	-$51.8M	–	3737
2019 Q3	$51.8M	Buy	2,192,020 +2,147,408	+4,814%	+$63.6M	0.01%	979
2019 Q2	$1.34M	Sell	44,612 -156,386	-78%	-$3.58M	﹤0.01%	2904
2019 Q1	$4.5M	Sell	200,998 -37,444	-16%	-$805K	﹤0.01%	2079
2018 Q4	$4.34M	Buy	+238,442	New	+$3.74M	﹤0.01%	2017

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Invesco's RARX Position: Q2 2020 in Review

Invesco sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 5,776 shares — an estimated $277K sold.

Invesco first reported a position in RARX in Q4 2018 and held it in 5 quarters. The position peaked at $51.8M in Q3 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Invesco reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Invesco sold 5,776 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $277K.
Invesco first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
Invesco's Ra Pharmaceuticals, Inc. Common Stock position peaked at $51.8M in Q3 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Invesco's 13F filing for Q2 2020, filed 14 Aug 2020.